The UK’s world-class expertise in the research of biofilms was recognised through the recent launch of the new National Biofilms Innovation Centre (NBIC). Supported by a commitment of £26 million over the next 5 years, including £12.5M funding from the Biotechnology and Biological Sciences Research Centre (BBSRC) and Innovate UK, with additional support from universities, industry […]
First Product Release from Inscripta’s Enzyme Engineering Platform Boulder, Colo. – In a huge step forward for innovation in the cutting-edge field of CRISPR gene-editing, Inscripta – a gene-editing technology company – announced today that it is releasing one of its own, unique CRISPR enzymes, which will be free for all researchers to use. Called […]
Aldevron and Integrated DNA Technologies, Inc. (IDT), a supplier of custom nucleic acid and genome editing products, have announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant—known as SpyFiTM Cas9 Nuclease—which is patented by IDT. The product will be manufactured for research, clinical, and commercial use. “IDT continues to be an innovator for the […]
SAN DIEGO—Illumina, Inc. (NASDAQ:ILMN) today announced Aimee Hoyt, an accomplished and strategic talent leader, will head its human resources team. Ms. Hoyt will join as Senior Vice President and Chief People Officer (CPO), starting January 8, 2018, and will be responsible for leading all aspects of the company’s HR strategies, reporting to the CEO. This press release features multimedia. […]
Phasefocus continues to increase its global international profile with the appointment of Nuohai Life Sciences as the company’s exclusive distributor for mainland China, Hong Kong and Macau. Nuohai Life Sciences will provide sales, service and technical support for the Livecyte™ Cell Imaging System throughout the region, building on their reputation for introducing innovative new technologies […]
Orgenesis and Pall Corporation originally received BIRD Grant in 2015 to co-develop a viral transduction production process for the treatment of diabetes. GERMANTOWN, Md. — Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc., (OTCQB:ORGSD) (“Orgenesis” or the “Company”), a vertically-integrated biopharmaceutical company with expertise and unique experience in gene and cell therapy and regenerative medicine, […]
Genovis is continuing to expand in Asia and has signed a distribution agreement with Allianz Bioinnovation for the Indian market. The agreement covers Genovis’ current and future product lines. The Indian market has grown substantially in recent years and the total biotech market in India is estimated at USD 11 billion, 64 percent of which […]
BIO-CAT is pleased to announce the hiring of Elaine Cooling as regulatory affairs manager. Elaine comes to BIO-CAT with over 15 years’ experience in quality, regulatory and manufacturing support roles primarily in the pharmaceutical industry, most recently with Allergen Pharmaceuticals International. Elaine’s role will oversee the daily regulatory needs of BIO-CAT’s customers, play a vital […]
Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it is transferring the U.S. listing of its global shares to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. The transfer to the NYSE is expected to be effective on or about January 10, 2018. QIAGEN’s […]
London, UK — Copenhagen Center for Glycomics (CCG) and Desktop Genetics (DTG) today announced a collaboration to develop the next-generation of CRISPR analysis. The project is designed to provide a deeper understanding of a novel method of identifying nuclease-generated mutations developed by the lab of Dr. Eric Paul Bennett. The method is currently used by CCG and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
